Pneumococal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistance. (Record no. 6014)

MARC details
000 -LEADER
fixed length control field 03053nam a22003617a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210217s20212021 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0954-6111
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.rmed.2021.106307 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code S0954-6111(21)00013-5 [pii]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 33486205
245 ## - TITLE STATEMENT
Title Pneumococal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistance.
251 ## - Source
Source Respiratory Medicine. 177:106307, 2021 Jan 08.
252 ## - Abbreviated Source
Abbreviated source Respir Med. 177:106307, 2021 Jan 08.
253 ## - Journal Name
Journal name Respiratory medicine
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2021
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2021
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
266 ## - Date added to catalog
Date added to catalog 2021-02-17
520 ## - SUMMARY, ETC.
Abstract BACKGROUND: Streptococcus pneumoniae (SP) remains the leading pathogen in community-acquired pneumonia (CAP). Despite the increasing prevalence of macrolide resistance in SP, guidelines recommend the use of macrolides as part of a combination regiment for intensive care unit (ICU) patients with CAP. We sought to describe if macrolide resistance effects outcomes in SP CAP in the ICU and if macrolides remain associated with a mortality advantage in an era of greater resistance.
520 ## - SUMMARY, ETC.
Abstract CONCLUSIONS: Macrolide resistance appears frequently in SP ICU CAP. The addition of azithromycin to the antibiotic regimen in this scenario is significantly associated with a reduction in in-hospital mortality independent of multiple co-variates. Copyright (c) 2021 Elsevier Ltd. All rights reserved.
520 ## - SUMMARY, ETC.
Abstract METHODS: We identified all patients with SP CAP admitted to the ICU between January 2012 and December 2016, and hospital mortality represented the primary endpoint. We recorded markers of acute and chronic disease severity (eg, Charlson score, need for mechanical ventilation and/or vasopressors) along with infection-related variables including the presence of macrolide resistance. We compared subjects treated with azithromycin to those not given this agent.
520 ## - SUMMARY, ETC.
Abstract RESULTS: The cohort included 140 subjects (89.2% on mechanical ventilation, 14.3% crude mortality). Macrolide resistance occurred often (60.8%) and, in univariate analyses, was associated with higher mortality while azithromycin use appeared linked to fewer death. In multivariate analysis controlling for multiple confounders including macrolide resistance and the timeliness and appropriateness of antibiotic therapy, treatment with azithromycin resulted in fewer death (Adjusted odds ratio 0.27, 95% confidence interval: 0.09-0.85, p = 0.024). Macrolide resistance, however, was not independently related to mortality.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Medicine/Pulmonary-Critical Care
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Shorr, Andrew F
790 ## - Authors
All authors Hampton N, Kollef MH, Micek ST, Shorr AF, Simmons J
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1016/j.rmed.2021.106307">https://dx.doi.org/10.1016/j.rmed.2021.106307</a>
Public note https://dx.doi.org/10.1016/j.rmed.2021.106307
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 02/17/2021   33486205 33486205 02/17/2021 02/17/2021 Journal Article

Powered by Koha